{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T18:59:10Z","timestamp":1767639550522,"version":"3.48.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Opioid dependence is highly prevalent within incarcerated populations, with one-fifth of all drug overdose deaths occurring among formerly incarcerated individuals. Opioid antagonists are promising in reversing overdoses, with naloxone widely recognised as a rapid and safe treatment for opioid toxicity. While community-based evidence demonstrates the efficacy of naloxone in reducing overdose deaths, its implementation in carceral settings is neither standardised nor embedded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This scoping review aims to systematically assess the acceptability, feasibility, and effectiveness of naloxone interventions in prisons and other detention settings globally, with the explicit goal of identifying research gaps and generating evidence to inform global prison policy, practice and future implementation research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A scoping review was conducted following Arksey and O\u2019Malley\u2019s framework. Literature searches were performed in PubMed, Scopus, and Embase for English-language records published between 2000 and 2025, in line with the PRISMA Extension for Scoping Reviews guidelines. Data were analysed using narrative synthesis as informed by Popay et al.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 1764 records initially identified, 24 records met the inclusion criteria. Three themes and associated sub-themes were identified. They were (a) current provision (naloxone distribution and benefits; Take-Home Naloxone programmes on community release; naloxone (intranasal) within carceral settings; rollout of naloxone vending machines), (b) population satisfaction (acceptability and feasibility; implementation readiness) and (c) organisational factors (barriers and challenges; facilitators and suggestions).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Naloxone provision in carceral settings is acceptable, feasible, and effective in preventing opioid overdoses during incarceration and after release. Strong support exists among prisoners and staff, yet significant gaps remain, particularly regarding use in vulnerable populations such as women, younger individuals, and immigration detainees. Integrating naloxone into prison health systems, alongside staff training and peer engagement, is a critical step in reducing preventable overdose deaths and enhancing continuity of care post-release.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12954-025-01358-x","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T17:32:01Z","timestamp":1764437521000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness, acceptability, and feasibility of naloxone in carceral settings: a scoping review"],"prefix":"10.1186","volume":"23","author":[{"given":"Nandakumar","family":"Ravichandran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Cullen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Claire","family":"Van Hout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Des","family":"Crowley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"issue":"12","key":"1358_CR1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.48667","volume":"7","author":"DR Balter","year":"2024","unstructured":"Balter DR, Howell BA. Take-home naloxone, release from jail, and opioid overdose\u2014a piece of the puzzle. JAMA Netw Open. 2024;7(12):e2448667-e.","journal-title":"JAMA Netw Open"},{"key":"1358_CR2","volume":"147","author":"DM Hartung","year":"2023","unstructured":"Hartung DM, McCracken CM, Nguyen T, Kempany K, Waddell EN. Fatal and nonfatal opioid overdose risk following release from prison: a retrospective cohort study using linked administrative data. J Subst Abuse Treat. 2023;147:208971.","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"1358_CR3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/ADM.0000000000000312","volume":"11","author":"YI Hser","year":"2017","unstructured":"Hser YI, Mooney LJ, Saxon AJ, Miotto K, Bell DS, Zhu Y, et al. High mortality among patients with opioid use disorder in a large healthcare system. J Addict Med. 2017;11(4):315\u20139.","journal-title":"J Addict Med"},{"issue":"1","key":"1358_CR4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40352-020-00113-7","volume":"8","author":"EN Waddell","year":"2020","unstructured":"Waddell EN, Baker R, Hartung DM, Hildebran CJ, Nguyen T, Collins DRM, et al. Reducing overdose after release from incarceration (ROAR): study protocol for an intervention to reduce risk of fatal and non-fatal opioid overdose among women after release from prison. Health Justice. 2020;8(1):18.","journal-title":"Health Justice"},{"issue":"1","key":"1358_CR5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13722-019-0145-5","volume":"14","author":"PJ Joudrey","year":"2019","unstructured":"Joudrey PJ, Khan MR, Wang EA, Scheidell JD, Edelman EJ, McInnes DK, et al. A conceptual model for understanding post-release opioid-related overdose risk. Addict Sci Clin Pract. 2019;14(1):17.","journal-title":"Addict Sci Clin Pract"},{"issue":"1","key":"1358_CR6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12954-021-00525-0","volume":"18","author":"C McCaughran-Contreras","year":"2021","unstructured":"McCaughran-Contreras C, Fernando S, Sikora M, Hawkins J, Kniseley M, Snyder D, et al. Substance use and overdose risk: documenting the perspectives of formerly incarcerated persons in the Fraser East region of BC. Harm Reduct J. 2021;18(1):77.","journal-title":"Harm Reduct J"},{"key":"1358_CR7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1940-0640-7-3","volume":"7","author":"I Binswanger","year":"2012","unstructured":"Binswanger I, Nowels C, Corsi K, Glanz J, Long J, Booth R, et al. Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors. Addict Sci Clin Pract. 2012;7:3.","journal-title":"Addict Sci Clin Pract"},{"issue":"4","key":"1358_CR8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","volume":"34","author":"D Ciccarone","year":"2021","unstructured":"Ciccarone D. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Curr Opin Psychiatry. 2021;34(4):344\u201350.","journal-title":"Curr Opin Psychiatry"},{"issue":"2","key":"1358_CR9","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/S2468-2667(24)00001-X","volume":"9","author":"A Holland","year":"2024","unstructured":"Holland A, Copeland CS, Shorter GW, Connolly DJ, Wiseman A, Mooney J, et al. Nitazenes\u2014heralding a second wave for the UK drug-related death crisis? Lancet Public Health. 2024;9(2):e71\u20132.","journal-title":"Lancet Public Health"},{"key":"1358_CR10","unstructured":"Centers for Disease Control and Prevention. Understanding the opioid overdose epidemic. 2025."},{"issue":"1","key":"1358_CR11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0885-3924(02)00424-4","volume":"24","author":"YS Choi","year":"2002","unstructured":"Choi YS, Billings JA. Opioid antagonists: a review of their role in palliative care, focusing on use in opioid-related constipation. J Pain Symptom Manag. 2002;24(1):71\u201390.","journal-title":"J Pain Symptom Manag"},{"key":"1358_CR12","unstructured":"Theriot J, Sabir S, Azadfard M. Opioid Antagonists. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2025, StatPearls Publishing LLC; 2025."},{"key":"1358_CR13","unstructured":"Theriot J, Sabir S, Azadfard M. Opioid Antagonists. StatPearls [Internet]. Updated 2023 Jul 21 ed. Treasure Island (FL): StatPearls Publishing; 2025."},{"key":"1358_CR14","unstructured":"Jordan MR, Patel P, Morrisonponce D. Naloxone. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2025, StatPearls Publishing LLC; 2025."},{"key":"1358_CR15","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103615","volume":"102","author":"C Spring","year":"2022","unstructured":"Spring C, Croxford S, Ward Z, Ayres R, Lord C, Desai M, et al. Perceived availability and carriage of take-home naloxone and factors associated with carriage among people who inject drugs in England, Wales and Northern Ireland. Int J Drug Policy. 2022;102:103615.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"1358_CR16","doi-asserted-by":"crossref","DOI":"10.1016\/j.japh.2025.102357","volume":"65","author":"E Gravlee","year":"2025","unstructured":"Gravlee E, Wartman C, Rosenthal M. Over-the-counter naloxone availability: insights from rural community pharmacists in the Southern United States. J Am Pharm Assoc. 2025;65(3):102357.","journal-title":"J Am Pharm Assoc"},{"issue":"5","key":"1358_CR17","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.13861","volume":"7","author":"X Zang","year":"2024","unstructured":"Zang X, Skinner A, Krieger MS, Behrends CN, Park JN, Green TC, et al. Evaluation of strategies to enhance community-based naloxone distribution supported by an opioid settlement. JAMA Netw Open. 2024;7(5):e2413861-e.","journal-title":"JAMA Netw Open"},{"key":"1358_CR18","unstructured":"Penal Reform International, Thailand Institute of J. Global Prison Trends 2025. London: Penal Reform International; 2025. 2025\/05."},{"key":"1358_CR19","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2019.102616","volume":"76","author":"H Alho","year":"2020","unstructured":"Alho H, Dematteis M, Lembo D, Maremmani I, Roncero C, Somaini L. Opioid-related deaths in Europe: strategies for a comprehensive approach to address a major public health concern. Int J Drug Policy. 2020;76:102616.","journal-title":"Int J Drug Policy"},{"issue":"8","key":"1358_CR20","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/add.13779","volume":"112","author":"J Marsden","year":"2017","unstructured":"Marsden J, Stillwell G, Jones H, Cooper A, Eastwood B, Farrell M, et al. Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England. Addiction. 2017;112(8):1408\u201318.","journal-title":"Addiction"},{"key":"1358_CR21","volume":"357","author":"L Sordo","year":"2017","unstructured":"Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550.","journal-title":"BMJ"},{"key":"1358_CR22","unstructured":"European Union Drugs Agency. European Drug Report 2024: Trends and Developments. 2024. https:\/\/www.euda.europa.eu\/publications\/european-drug-report\/2024_en."},{"key":"1358_CR23","unstructured":"World Health Organization. WHO joins 67th session of the Commission on Narcotic Drugs. 2024."},{"key":"1358_CR24","unstructured":"The Commission on Narcotic Drugs. 2024 CND Resolution 67\/4. Preventing and responding to drug overdose through prevention, treatment, care and recovery measures, as well as other public health interventions to address the harms associated with illicit drug use. 2024. https:\/\/www.unodc.org\/rddb\/document\/drugs\/resolution\/2024\/67\/67-4\/"},{"key":"1358_CR25","unstructured":"[Irish Prison Service] Irish Prison Service launches life-saving initiative to combat opioid overdoses among prisoners. 2023."},{"key":"1358_CR26","unstructured":"HRB National Drugs Library. Deaths Data. 2024. https:\/\/www.drugsandalcohol.ie\/deaths-data\/#:~:text=The%20most%20recent%20bulletin%20(with,in%2Dten%20deaths%20in%202021."},{"key":"1358_CR27","unstructured":"Trust F. Take Home Naloxone: best practice in preventing fatal opioid overdoses for prison leavers. 2019. https:\/\/www.drugsandalcohol.ie\/30764\/."},{"key":"1358_CR28","unstructured":"Health. Do. Minister Naughton reaffirms commitment to lifesaving Naloxone programme. https:\/\/www.gov.ie\/en\/department-of-health\/press-releases\/minister-naughton-reaffirms-commitment-to-lifesaving-naloxone-programme\/."},{"key":"1358_CR29","unstructured":"Ireland. Go. Minister Flanagan launches Irish Prison Service Strategic Plan 2019\u20132022 & IPS\/ETBI Prisons Education Strategy 2019\u20132022. 2019. https:\/\/www.gov.ie\/ga\/an-roinn-dl%C3%AD-agus-cirt-gn%C3%B3tha%C3%AD-baile-agus-imirce\/preaseisiuinti\/minister-flanagan-launches-irish-prison-service-strategic-plan-2019-2022-ipsetbi-prisons-education-strategy-2019-2022\/."},{"issue":"4","key":"1358_CR30","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/dar.12542","volume":"37","author":"K Horsburgh","year":"2018","unstructured":"Horsburgh K, McAuley A. Scotland\u2019s national naloxone program: the prison experience. Drug Alcohol Rev. 2018;37(4):454\u20136.","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"1358_CR31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1748-5908-5-69","volume":"5","author":"D Levac","year":"2010","unstructured":"Levac D, Colquhoun H, O\u2019Brien KK. Scoping studies: advancing the methodology. Implement Sci. 2010;5(1):69.","journal-title":"Implement Sci"},{"issue":"1","key":"1358_CR32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","volume":"8","author":"H Arksey","year":"2005","unstructured":"Arksey H, O\u2019Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19\u201332.","journal-title":"Int J Soc Res Methodol"},{"issue":"Suppl 1","key":"1358_CR33","first-page":"A7","volume":"59","author":"J Popay","year":"2005","unstructured":"Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, et al. Guidance on the conduct of narrative synthesis in systematic reviews final report. J Epidemiol Community Health. 2005;59(Suppl 1):A7.","journal-title":"J Epidemiol Community Health"},{"issue":"2","key":"1358_CR34","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/10550880902772423","volume":"28","author":"SE Wakeman","year":"2009","unstructured":"Wakeman SE, Bowman SE, McKenzie M, Jeronimo A, Rich JD. Preventing death among the recently incarcerated: an argument for naloxone prescription before release. J Addict Dis. 2009;28(2):124\u20139.","journal-title":"J Addict Dis"},{"issue":"6","key":"1358_CR35","doi-asserted-by":"crossref","first-page":"393","DOI":"10.5055\/jom.2013.0181","volume":"9","author":"KL Cropsey","year":"2013","unstructured":"Cropsey KL, Martin S, Clark CB, McCullumsmith CB, Lane PS, Hardy S, et al. Characterization of opioid overdose and response in a high-risk community corrections sample: a preliminary study. J Opioid Manag. 2013;9(6):393\u2013400.","journal-title":"J Opioid Manag"},{"issue":"5","key":"1358_CR36","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/add.13265","volume":"111","author":"SM Bird","year":"2016","unstructured":"Bird SM, McAuley A, Perry S, Hunter C. Effectiveness of Scotland\u2019s National Naloxone Programme for reducing opioid-related deaths: a before (2006\u201310) versus after (2011\u201313) comparison. Addiction. 2016;111(5):883\u201391.","journal-title":"Addiction"},{"issue":"1","key":"1358_CR37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12954-016-0094-1","volume":"13","author":"A Sondhi","year":"2016","unstructured":"Sondhi A, Ryan G, Day E. Stakeholder perceptions and operational barriers in the training and distribution of take-home naloxone within prisons in England. Harm Reduct J. 2016;13(1):5.","journal-title":"Harm Reduct J"},{"issue":"3","key":"1358_CR38","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/add.13668","volume":"112","author":"MK Parmar","year":"2017","unstructured":"Parmar MK, Strang J, Choo L, Meade AM, Bird SM. Randomized controlled pilot trial of naloxone-on-release to prevent post-prison opioid overdose deaths. Addiction. 2017;112(3):502\u201315.","journal-title":"Addiction"},{"issue":"1","key":"1358_CR39","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12954-017-0200-z","volume":"14","author":"AG Petterson","year":"2017","unstructured":"Petterson AG, Madah-Amiri D. Overdose prevention training with naloxone distribution in a prison in Oslo, Norway: a preliminary study. Harm Reduct J. 2017;14(1):74.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1358_CR40","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12954-018-0255-5","volume":"15","author":"M Curtis","year":"2018","unstructured":"Curtis M, Dietze P, Aitken C, Kirwan A, Kinner SA, Butler T, et al. Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use. Harm Reduct J. 2018;15(1):48.","journal-title":"Harm Reduct J"},{"issue":"4","key":"1358_CR41","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jamapsychiatry.2017.4614","volume":"75","author":"TC Green","year":"2018","unstructured":"Green TC, Clarke J, Brinkley-Rubinstein L, Marshall BDL, Alexander-Scott N, Boss R, et al. Postincarceration fatal overdoses after implementing medications for addiction treatment in a statewide correctional system. JAMA Psychiatr. 2018;75(4):405\u20137.","journal-title":"JAMA Psychiatr"},{"key":"1358_CR42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.addbeh.2018.12.017","volume":"92","author":"PJ Davidson","year":"2019","unstructured":"Davidson PJ, Wagner KD, Tokar PL, Scholar S. Documenting need for naloxone distribution in the Los Angeles County jail system. Addict Behav. 2019;92:20\u20133.","journal-title":"Addict Behav"},{"issue":"1","key":"1358_CR43","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1108\/IJPH-12-2017-0058","volume":"15","author":"LA Pearce","year":"2019","unstructured":"Pearce LA, Mathany L, Rothon D, Kuo M, Buxton JA. An evaluation of Take Home Naloxone program implementation in British Columbian correctional facilities. Int J Prisoner Health. 2019;15(1):46\u201357.","journal-title":"Int J Prisoner Health"},{"issue":"4","key":"1358_CR44","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/1078345819882771","volume":"25","author":"LD Wenger","year":"2019","unstructured":"Wenger LD, Showalter D, Lambdin B, Leiva D, Wheeler E, Davidson PJ, et al. Overdose education and naloxone distribution in the San Francisco County Jail. J Correct Health Care. 2019;25(4):394\u2013404.","journal-title":"J Correct Health Care"},{"issue":"5","key":"1358_CR45","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1177\/1524839920950028","volume":"22","author":"S Chambers","year":"2021","unstructured":"Chambers S, Baca M, Navrotskaya E, Madaras A, Rhyne RL, Hettema J, et al. Pilot study of an overdose first aid program in juvenile detention. Health Promot Pract. 2021;22(5):638\u201340.","journal-title":"Health Promot Pract"},{"issue":"1","key":"1358_CR46","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/dar.13144","volume":"40","author":"B Moradmand-Badie","year":"2021","unstructured":"Moradmand-Badie B, Tran L, Oikarainen N, Degenhardt L, Nielsen S, Roberts J, et al. Feasibility and acceptability of take-home naloxone for people released from prison in New South Wales, Australia. Drug Alcohol Rev. 2021;40(1):98\u2013108.","journal-title":"Drug Alcohol Rev"},{"issue":"4","key":"1358_CR47","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1108\/IJPH-01-2021-0004","volume":"17","author":"M Reed","year":"2021","unstructured":"Reed M, Siegler A, Tabb LP, Momplaisir F, Krevitz D, Lankenau S. Changes in overdose knowledge and attitudes in an incarcerated sample of people living with HIV. Int J Prison Health. 2021;17(4):560\u201373.","journal-title":"Int J Prison Health"},{"key":"1358_CR48","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2021.114293","volume":"285","author":"D Showalter","year":"2021","unstructured":"Showalter D, Wenger LD, Lambdin BH, Wheeler E, Binswanger I, Kral AH. Bridging institutional logics: implementing naloxone distribution for people exiting jail in three California counties. Soc Sci Med. 2021;285:114293.","journal-title":"Soc Sci Med"},{"issue":"1","key":"1358_CR49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1108\/IJPH-04-2021-0033","volume":"18","author":"KE McLeod","year":"2022","unstructured":"McLeod KE, Xavier J, Okhowat A, Williams S, Korchinski M, Young P, et al. Knowledge of the Good Samaritan Drug Overdose Act and possession of a naloxone kit among people recently released from prison. Int J Prison Health. 2022;18(1):43\u201354.","journal-title":"Int J Prison Health"},{"key":"1358_CR50","volume":"147","author":"NT Tran","year":"2023","unstructured":"Tran NT, Muradian IK, Qureshi N, Singh J, Henderson SO. Characterizing and combating the opioid epidemic in the Los Angeles County jail system. J Subst Use Addict Treat. 2023;147:208984.","journal-title":"J Subst Use Addict Treat"},{"issue":"1","key":"1358_CR51","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40352-024-00283-8","volume":"12","author":"CB Oser","year":"2024","unstructured":"Oser CB, McGladrey M, Booty M, Surratt H, Knudsen HK, Freeman PR, et al. Rapid jail-based implementation of overdose education and naloxone distribution in response to the COVID-19 pandemic. Health Justice. 2024;12(1):27.","journal-title":"Health Justice"},{"issue":"1","key":"1358_CR52","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1108\/IJOPH-01-2023-0008","volume":"20","author":"RR Ricciardelli","year":"2023","unstructured":"Ricciardelli RR, Johnston MS, Maier K. \u201cWe don\u2019t even know where it\u2019s kept\u201d: exploring perspectives on naloxone administration by provincial correctional workers in Manitoba, Canada. Int J Prison Health. 2023;20(1):30\u201346.","journal-title":"Int J Prison Health"},{"issue":"1","key":"1358_CR53","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40352-024-00307-3","volume":"12","author":"J Sprunger","year":"2024","unstructured":"Sprunger J, Brown J, Rubi S, Papp J, Lyons M, Winhusen TJ. Jail-based interventions to reduce risk for opioid-related overdose deaths: examples of implementation within Ohio counties participating in the HEALing Communities Study. Health Justice. 2024;12(1):48.","journal-title":"Health Justice"},{"key":"1358_CR54","volume":"167","author":"G Victor","year":"2024","unstructured":"Victor G, Hedden-Clayton B, Lenz D, Attaway PR, Ray B. Naloxone vending machines in county jail. J Subst Use Addict Treat. 2024;167:209521.","journal-title":"J Subst Use Addict Treat"},{"issue":"6","key":"1358_CR55","doi-asserted-by":"crossref","DOI":"10.1016\/j.hlpt.2025.101072","volume":"14","author":"TJ Adams","year":"2025","unstructured":"Adams TJ, Teck JTW, Baldacchino A, Forget P. An impact evaluation of the Scottish take-home naloxone programme. Health Policy Technol. 2025;14(6):101072.","journal-title":"Health Policy Technol"},{"key":"1358_CR56","volume":"169","author":"R Martin","year":"2025","unstructured":"Martin R, DaCunha A, Bailey A, Joseph R, Kane K. Evaluating public health vending machine rollout and utilization in criminal-legal settings. J Subst Use Addict Treat. 2025;169:209584.","journal-title":"J Subst Use Addict Treat"},{"issue":"1","key":"1358_CR57","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40352-025-00337-5","volume":"13","author":"M Staton","year":"2025","unstructured":"Staton M, Dickson MF, Levi MM, Tillson M, Freeman PR, Fanucchi LC, et al. Overdose education and naloxone distribution among women with a history of OUD transitioning to the community following jail release. Health Justice. 2025;13(1):33.","journal-title":"Health Justice"},{"key":"1358_CR58","unstructured":"Scottish Drugs Forum. Peer naloxone supply project: An evaluation of three pilot areas. 2023."},{"key":"1358_CR59","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.06.038","volume":"204","author":"RB Naumann","year":"2019","unstructured":"Naumann RB, Durrance CP, Ranapurwala SI, Austin AE, Proescholdbell S, Childs R, et al. Impact of a community-based naloxone distribution program on opioid overdose death rates. Drug Alcohol Depend. 2019;204:107536.","journal-title":"Drug Alcohol Depend"},{"key":"1358_CR60","volume":"15","author":"K Frederiks","year":"2025","unstructured":"Frederiks K, Everett M, Powell KG, Peterson NA, Borys S, Hallcom DK, et al. Reported outcomes from a community naloxone training and distribution program. Drug Alcohol Depend Rep. 2025;15:100341.","journal-title":"Drug Alcohol Depend Rep"},{"key":"1358_CR61","volume":"160","author":"MAG Estrada","year":"2024","unstructured":"Estrada MAG, Abraham AJ, Andrews CM, Grogan CM. Statewide efforts to address the opioid epidemic: results from a national survey of single state agencies. J Subst Use Addict Treat. 2024;160:209309.","journal-title":"J Subst Use Addict Treat"},{"issue":"1","key":"1358_CR62","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1186\/s12889-025-22210-8","volume":"25","author":"LS Fischer","year":"2025","unstructured":"Fischer LS, Asher A, Stein R, Becasen J, Doreson A, Mermin J, et al. Effectiveness of naloxone distribution in community settings to reduce opioid overdose deaths among people who use drugs: a systematic review and meta-analysis. BMC Public Health. 2025;25(1):1135.","journal-title":"BMC Public Health"},{"key":"1358_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy11030088","author":"J Schofield","year":"2023","unstructured":"Schofield J, Parkes T, Mercer F, Foster R, Hn\u00edzdilov\u00e1 K, Matheson C, et al. Feasibility and acceptability of an overdose prevention intervention delivered by community pharmacists for patients prescribed opioids for chronic non-cancer pain. Pharmacy. 2023. https:\/\/doi.org\/10.3390\/pharmacy11030088.","journal-title":"Pharmacy"},{"issue":"12","key":"1358_CR64","doi-asserted-by":"crossref","first-page":"e2448732","DOI":"10.1001\/jamanetworkopen.2024.48732","volume":"7","author":"E Tatara","year":"2024","unstructured":"Tatara E, Ozik J, Pollack HA, Schneider JA, Friedman SR, Harawa NT, et al. Agent-based model of combined community- and jail-based take-home naloxone distribution. JAMA Netw Open. 2024;7(12):e2448732-e.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1358_CR65","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40352-025-00353-5","volume":"13","author":"T Hunt","year":"2025","unstructured":"Hunt T, Oser CB, Friedmann PD, Mack N, Balvanz P, Freisthler B, et al. Overdose education and naloxone distribution in jails: examining the impact of the Communities That HEAL intervention in 4 states. Health Justice. 2025;13(1):47.","journal-title":"Health Justice"},{"key":"1358_CR66","unstructured":"RTE News. Eight prisoners hospitalised after suspected overdoses at Portlaoise Prison. 2024 2024\/08\/13."},{"key":"1358_CR67","unstructured":"Scottish Drugs Forum. Framework for the supply of Naloxone within Scottish Prisons. 2022."},{"key":"1358_CR68","unstructured":"Horsburgh, Kirsten. My first 48 hours out. Naloxone-on-Release: Guidelines for naloxone provision upon release from prison and other custodial settings. Frankfurt: Frankfurt University of Applied Sciences. 2021."},{"key":"1358_CR69","unstructured":"Office of the Inspector of Prisons. Watchdog calls for action to reduce risk of prison overdoses. 2024 2024\/07\/19."},{"key":"1358_CR70","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.drugpo.2017.05.015","volume":"46","author":"M Horton","year":"2017","unstructured":"Horton M, McDonald R, Green TC, Nielsen S, Strang J, Degenhardt L, et al. A mapping review of take-home naloxone for people released from correctional settings. Int J Drug Policy. 2017;46:7\u201316.","journal-title":"Int J Drug Policy"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01358-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01358-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01358-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:16:10Z","timestamp":1767626170000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12954-025-01358-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1358"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01358-x","relation":{},"ISSN":["1477-7517"],"issn-type":[{"type":"electronic","value":"1477-7517"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}